CTI BioPharma Corp. | Key People and Executives
Adam R. Craig
President, Chief Executive Officer & Director
David R. Parkinson
Director
Matthew D. Perry
Independent Non-Executive Director
Michael A. Metzger
Independent Director
Frederick W. Telling
Independent Non-Executive Director
Reed Vaughn Tuckson
Independent Non-Executive Director
Adam R. Craig
President, Chief Executive Officer & Director
Bruce J. Seeley
COO, Secretary, Chief Administrative Officer & EVP
David H. Kirske
Chief Financial Officer & Executive VP
David R. Parkinson
Director
Ed Bell
Investor Relations Contact
Matthew D. Perry
Independent Non-Executive Director
Michael A. Metzger
Independent Director
Frederick W. Telling
Independent Non-Executive Director
Reed Vaughn Tuckson
Independent Non-Executive Director
| Address |
3101 Western Avenue
Seattle Washington 98121
United States
|
|
Employees
|
- |
| Website |
http://www.ctibiopharma.com |
| Updated |
07/08/2019 |
| CTI BioPharma Corp. operates as a biopharmaceutical company, which focuses on the development, acquisition, and commercialization of novel targeted therapies for blood-related cancers. Its products include PIXUVRI, Pacritinib, Tosedostat and Opaxio. The company was founded by James A. |
